Skip to content
healthcare.dev

Lapatinib

NDC 0480-3237, Lapatinib, tablet, film coated, from Teva Pharmaceuticals, Inc..

Product NDC
0480-3237
Status
Listed
Labeler
Teva Pharmaceuticals, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA217968
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0480-3237 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LAPATINIB DITOSYLATE250 mg/1

Pharmacologic classes

Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]

Package NDCNDC-11Package
0480-3237-5100480323751150 TABLET, FILM COATED in 1 BOTTLE (0480-3237-51)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b09abf73-1eef-4e12-b400-c030d546d223

Use it

Look up 0480-3237 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0480-3237 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0480-3237. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.